Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Retained Earnings: 2015-2025

Historic Retained Earnings for Seres Therapeutics (MCRB) over the last 11 years, with Sep 2025 value amounting to -$957.1 million.

  • Seres Therapeutics' Retained Earnings rose 0.56% to -$957.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$957.1 million, marking a year-over-year increase of 0.56%. This contributed to the annual value of -$978.1 million for FY2024, which is 0.01% up from last year.
  • Latest data reveals that Seres Therapeutics reported Retained Earnings of -$957.1 million as of Q3 2025, which was up 0.85% from -$965.3 million recorded in Q2 2025.
  • In the past 5 years, Seres Therapeutics' Retained Earnings registered a high of -$564.4 million during Q3 2021, and its lowest value of -$1.1 billion during Q2 2024.
  • Over the past 3 years, Seres Therapeutics' median Retained Earnings value was -$962.5 million (recorded in 2024), while the average stood at -$965.3 million.
  • In the last 5 years, Seres Therapeutics' Retained Earnings slumped by 41.00% in 2022 and then grew by 8.18% in 2025.
  • Quarterly analysis of 5 years shows Seres Therapeutics' Retained Earnings stood at -$614.4 million in 2021, then plummeted by 40.72% to -$864.5 million in 2022, then dropped by 13.15% to -$978.2 million in 2023, then increased by 0.01% to -$978.1 million in 2024, then rose by 0.56% to -$957.1 million in 2025.
  • Its last three reported values are -$957.1 million in Q3 2025, -$965.3 million for Q2 2025, and -$945.4 million during Q1 2025.